SEC Form 4 · accession 0000899243-15-007674
MyoKardia Inc · MYOK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Anastasios Gianakakos
Officer — President and CEO · Director
Period of report
Nov 3, 2015
Accepted (ET)
Nov 5, 2015 · 8:38 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001552451
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 3, 2015 | P | 1,350 | $10.00 | A | 482,165 | D | |
| Common StockF2 | holding | — | — | — | 204,081 | I | Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares were purchased through a directed share program in connection with the initial public offering of the Issuer.
- F2These shares are held by the Tassos Gianakakos 2015 Annuity Trust, dated September 25, 2015. The Reporting Person as trustee has sole dispositive power over these shares.